General Neuro side effects:

Small fiber neuropathy:
2 cases of Parsonage Turner Syndrome following Moderna and Pfizer:
Trigeminal Neuralgia and cervical radiculitis after Pfizer:
Neuralgic amyotrophy following mRNA vaccination:
Amyotrophic neuralgia secondary to AstraZeneca:
36yoM with transverse myelitis following AstraZeneca:
Acute Myelitis following AstraZeneca:
67yoF with transverse myelitis following Moderna 1st dose:
Longitudinal extensive transverse myelitis following AstraZeneca:
Transverse Myelitis and Bells Palsy after J&J vaccination:
Recurrent GBS following mRNA vaccination:
GBS following Johnson and Johnson:
4 cases of GBS following Astra Zeneca:
GBS following 2nd dose of Pfizer:
GBS after the first dose of Pfizer:
GBS in a 25yoF following 2nd dose of Pfizer:
GBS in a 61yoM following Moderna:
GBS in a 65yoM liver transplant patient following Pfizer:
GBS in a 73yoM following Moderna:
GBS in 73yoM following 2nd dose of Pfizer:
GBS in 82yoF following 1st dose Pfizer:
GBS 10 days after AstraZeneca:
GBS 11 days after AstraZeneca:
GBS following AstraZeneca:
7 cases of GBS following AstraZeneca:
GBS following AstraZeneca with papilledema as atypical onset:
2 cases of Sensory GBS following AstraZeneca:
Bilateral facial weakness with paresthesia variant of GBS following AstraZeneca:
Bifacial diplegia variant of GBS following J&J vaccination:
Facial Weakness, extremity weakness, encephalopathy, and severe refractory ITP following Moderna:
Transient akathisia after Pfizer:
21yoF nurse with Bells Palsy following Pfizer:
34yoF with Bells Palsy 2 days after Moderna:
36yo with Bells Palsy, left arm tingling/numbness/weakness following mRNA vaccination:
37yoM with Bells Palsy after Pfizer:
50yoM with Bells Palsy after Pfizer, ongoing symptoms after 21 days:
57yoF with Bells Palsy <36 hours after 2nd dose of Pfizer:
61yoM with Bells Palsy after each dose of Pfizer:
Bells Palsy following mRNA and inactivated (CoronaVac) vaccines: a case series and nested case-control study:
Rate of Bells Palsy following mRNA vaccination is 2-3x higher then expected:
Neuromyelitis optica spectrum disorder (NMOSD):
Patient’s first MS Flare following Pfizer:
4 cases of activation of stable MS, 2 cases of new MS, 1 case of new onset neuromyelitis optica after mRNA vaccination:
Severe Multiple Sclerosis relapse after Pfizer:
Optic neuritis and transverse myelitis in MS patient after Astrazeneca vaccination:
Myasthenia Gravis Flare Following Moderna:
CVA and Thrombocytopenia following Astrazeneca:
Central venous sinus thrombosis with subarachnoid hemorrhage in a 45yoM following Moderna:
Cerebral venous thrombosis and pulmonary embolus following AstraZeneca:
Cerebral venous sinus thrombosis after AstraZeneca, neurologic and radiological management:
Cerebral venous sinus thrombosis, subarachnoid hemorrhage, and thrombocytopenia following AstraZeneca:
Cerebral Venous sinus thrombosis, review of European cases:
Review of European data of Cerebral venous thrombosis with cytopenia, observed in Pfizer, Moderna, and AstraZeneca:
A multicenter cohort study of cerebral venous thrombosis after AstraZeneca Vaccination:
45 cases of Cerebral Venous thrombosis:
International Cerebral Venous Thrombosis consortium report on cerebral venous thrombosis following vaccination against SARS-COV-2:
Fatal ICH following AstraZeneca:
Treatment of AstraZeneca induced immume thrombotic thrombocytopenia related acute ischemic stroke:
Worsening Neuro-Oncologic Disease Symptoms following mRNA vaccination:
Clinical characteristics of Headache following Pfizer, a multicenter observational cohort study:
Aseptic Meningitis following Pfizer:
Delirium in an elderly patient following Pfizer:
Delirium in an elderly patient following vaccination:
Two cases of encephalopathy and seizures following Moderna:
Acute disseminated encephalitis following Pfizer:
Acute Disseminated Encephalitis in a young female following mRNA vaccination:
Postvaccinal encephalitis following AstraZeneca:
Acute encephalitis, myoclonus, and sweet syndrome after mRNA vaccine:
New onset psychosis in 31yoM after mRNA vaccine:
Severe dyskinesia in Parkinson Patient following mRNA vaccination:
Cytotoxic lesion of the Corpus Callousum following mRNA vaccination:
Myeloperoxidase anti-neutrophil cytoplasmic antibody positive optic perineuritis after mRNA vaccination:
Three cases: CVA, left facial nerve palsy, and myelitis all following AstraZeneca:
Headache after AstraZeneca: a MultiCenter observational cohort center:
Characteristics of COVID vaccine induced Headache:
Covid Vaccines are not free of Neurologic side effects:
Rebuttal about Functional Neurologic Disorders and Vaccination:
Neurologic safety monitoring of COVID-19 vaccines, lessons learned from the past to inform the present:

Excess VaXXine Cardiac Injuries:

Myocarditis in 23 military members:
Perimyocarditis in teens:
Vaccination associated myocarditis in Adolescents:
mRNA vaccination and myocarditis in adolescents:
Association of myocarditis with mRNA vaccination, a case review in children:
Recurrence of myocarditis after vaccination:
Myopericarditis in young adults presenting to the ED:
Pericarditis following mRNA vaccination:
Myocarditis following J&J in a healthy, young male:
Acute myocarditis after Moderna in young male:
Myocarditis in a healthy male:
Acute myocarditis following vaccination:
Acute myocarditis following Pfizer in a healthy man with previous COVID infection:
Myocarditis case report:
Myocarditis following mRNA vaccination:
Myocarditis in 24yoM:
Myocarditis in a 24yoM nurse after Pfizer:
Myocarditis in a 15yo following Pfizer:
Myopericarditis in a 16yo following vaccination: in a 22yoM following Moderna:
70yoF with myocarditis following J&J Vaccination:
Biopsy proven lymphocytic myocarditis following 1st mRNA vaccination in a 40yo:
Cardiac imaging of acute myocarditis following mRNA in a 24yoM:
Cardiac MRI findings in young adults following mRNA vaccination: a case series:
Myopericarditis following mRNA vaccination: the role of cardiac biomarkers and multimodality imaging: should be consider in those with a troponin rise and unobstructed arteries following Pfizer vaccination:
Myocarditis Associated with COVID-19 vaccination: echocardiography, cardiac tomography, and magnetic resonance imaging findings:
Fulminant myocarditis and systemic hyperinflammation in 2 patients following mRNA:
2 cases of histological confirmed myocarditis following mRNA vaccination:
Myocarditis and Pericarditis: 2 case reports:
Two cases of myocarditis:
Two cases of myocarditis:
3 cases of cardiac manifestation following Pfizer:
4 cases of Myocarditis and their Cardiac MRI findings:
4 cases of myocarditis:
6 cases of men age 17-37 with myocarditis:
8 cases of myocarditis in adolescents following Pfizer:
13 cases of Myocarditis in adolescents following Pfizer:
Review of 15 published cases of myocarditis:
Review of 29 published cases of acute myopericarditis following mRNA vaccination:
Review of 214 myocarditis cases:
JAMA article, concerns for perimyocarditis underreporting, review of 40 hospitals:
Intravenous injection of mRNA vaccine can induce acute myopericarditis in mouse model:
The Novel platform of mRNA vaccines and myocarditis - clues into the potential underlying mechanism:
3 cases of acute infarct-like myocarditis (2 Pfizer, 1 AstraZeneca):
2 cases of acute MI <24 hours after mRNA vaccination:
Acute STEMI MI following AstraZeneca vaccination,?Kounis syndrome?:
Vaccine induced immune thrombocytopenia and thrombosis associated anterior ST-elevation myocardial infarction following AstraZeneca:
Frequent PVS and NSVT following 2nd dose of Pfizer:
Isolated tachycardia in a 29yoF following Pfizer:
Covid-19 vaccine associated Takotsubo cardiomyopathy:
63yoF with Takotsubo cardiomyopathy following Moderna:
Tachycardia following Pfizer: 3 cases in those previously infected with COVID-19:
Dizziness, HTN and new LBBB following AstraZeneca vaccination:

Excess VaXXine Gastrointestinal Injuries:

Gastroparesis following Pfizer:
Acute Necrotizing Pancreatitis following 2nd dose of Pfizer:
Acute Pancreatitis in a 96yoF following 1st dose of Pfizer:
Cutaneous hypersensitivity reaction with acute hepatitis following Pfizer 2nd dose:
41yo F with Autoimmune hepatitis following Moderna:
76yoF with autoimmune hepatitis following Moderna Vaccination:
71yoF with Autoimmune hepatitis after mRNA vaccine (Moderna):
80yoF with autoimmune hepatitis following Pfizer:
63yoM with autoimmune hepatitis following Moderna:
61yoF with liver injury following Pfizer:
35yoF with autoimmune hepatitis following Pfizer:
New Onset autoimmune hepatitis following mRNA vaccination in a 36yoF with Primary Sclerosing Cholangitis:
56yoF with autoimmune hepatitis following Moderna:
Two cases of autoimmune hepatitis following AstraZeneca:
Liver injury in a liver transplant patient following mRNA vaccination:
16 cases of liver injury following Pfizer and Moderna: a multicenter case series:
Reactivation of Hepatitis C infection following Pfizer in a 82yoF:
Unusual fever, HA, and abdominal pain in a healthy woman following AstraZeneca:
Hepatic vein thrombosis due to TTS following AstraZeneca:

Excess VaXXine Renal Injuries:
ANCA glomerulonephritis after Moderna:
New onset ANCA vasculitis after Pfizer:
ANCA associated Glomerulonephritis following Pfizer:
Nephrotic Syndrome following AstraZeneca:
New onset Nephrotic syndrome following J&J:
Nephrotic syndrome and vasculitis following Pfizer, Moderna, and AstraZeneca:
De novo vasculitis after Moderna:
ANCA associated vasculitis following AstraZeneca: and crescentic glomerulonephritis following Pfizer:
Minimal Change Disease Following Pfizer:
Minimal Change Disease relapse following Pfizer:
MCD relapse following Pfizer:
MCD relapse following Pfizer:
Severe MCD relapse 3 days following Pfizer:
Minimal change disease and AKI following Pfizer:
Minimal Change disease following Moderna:
Minimal Change disease and Severe AKI following AstraZeneca:
3 cases of minimal change disease following 2nd dose of mRNA vaccine:
IgA nephropathy in 2 pediatric patients after Pfizer:
3 cases of IgA nephropathy patients developing exacerbations following mRNA vaccine:
2 cases of IgA nephropathy patients developing exacerbations following moderna:
IgA nephropathy flare up following Moderna:
IgA Nephropathy after mRNA vaccine:
2 cases of IgA Nephropathy patients developing hematuria after Pfizer:
Reactivation of IgA vasculitis following Moderna:
IgA vasculitis following AstraZeneca:
IgA nephropathy flare-up following vaccination:
Membranous nephropathy following mRNA vaccination:
Membranous nephropathy following Pfizer:
Renal Thrombotic Microangiopathy following Pfizer in a 35yoM:
Lupus exacerbation:
Lupus exacerbation following mRNA vaccination:
Systemic lupus following vaccination:
Relapse of class V lupus. Nephritis after mRNA vaccination:
Subacute cutaneous lupus erythematosus flare triggered by Moderna:
Emergence of new onset SLE following vaccination:
Hyperglycemic crisis:
Perturbation of blood glucose following vaccination, a review of 20 adults:
Subacute Thyroiditis:
Two cases of subacute thyroiditis after Moderna and AstraZeneca:
Two cases of Graves disease following vaccination:
Two more cases of Graves disease following Pfizer:
5 cases of adrenal crisis following AstraZeneca:
Myositis in a 56yoF following mRNA vaccination:
mRNA induced rhabdomyolysis and fasciitis:
Rhabdomyolysis after Moderna:
21yoM with Pfizer induced rhabdomyolysis:
Quadrilateral space region inflammation and other incidental findings on shoulder MRI following Pfizer COVID-19 vaccination:
Rash, arthritis, swelling, muscle weakness following AstraZeneca:
Polyarthralgia and Myalgia syndrome after AstraZeneca:
40yoF with Henoch-Schonlein Purpura following Pfizer:
New onset mainly guttate psoriasis after Pfizer:
2 cases of exacerbation of plaque psoriasis after Pfizer and CoronaVac:
14 cases of psoriasis activation following vaccination (Moderna, Pfizer, and AstraZeneca):
Pustuluar psoriasis following AstraZeneca:
Psorasis exacerbation after AstraZeneca:
Arthritis in the L elbow following vaccination:
Vasculitis and bursitis on 18F FDG-PET/CT following mRNA vaccination:
Remitting seronegative symmetrical synovitis with pitting edema following Pfizer:
Scleroderma renal crisis following mRNA vaccination:
Adult onset Still’s disease following AstraZeneca:
Adult onset Still’s disease following mRNA vaccine:
Hyper-inflammation after COVID-19 mRNA vaccination: at the cross roads of multi-inflammatory disease and adult onset still’s disease:
Immune mediated disease flares:
Local and systemic reactogenicity of Pfizer in patients with systemic lupus and rheumatoid arthritis:
Incidence of disease flare after Pfizer vaccination in patients with rheumatoid arthritis in remission:
11% of patients with rheumatic and MSK diseases report disease flare following 2 dose mRNA vaccination:

Excess VaXXine Hematological Injuries:

Superior ophthalmic Vein Thrombosis and Thrombocytopenia following AstraZeneca:
Autoimmune hemolytic anemia:
Autoimmine hemolytic anemia following Pfizer:
ITP and AIHA following Moderna:
ITP Exacerbation in 12% of chronic patients:
ITP Exacerbation in previous stable patient following Pfizer:
ITP following Pfizer:
ITP following Pfizer:
Secondary ITP and resulting hemorrhage and hematoma after minor oral surgery after Pfizer:
ITP and diffuse papular rash following Moderna:
ITP following Astrazeneca:
ITP in 1st trimester of pregnancy 13 days following vaccination in the US:
84yoM with ITP following Pfizer:
41yoF with ITP following Pfizer:
69yoF with refractory ITP following Pfizer:
20yoF with ITP following Pfizer:
54yoF with ITP following Pfizer:
74yoM with ITP following Moderna:
26yoF with ITP and acute liver injury following Moderna:
26yoF with ITP following Moderna:
63yoF with ITP following Johnson and Johnson:
68yoF with ITP following Moderna:
86yoM with ITP following AstraZeneca:
41yoM with ITP following AstraZeneca:
3 cases of ITP following Pfizer and Astra Zeneca:
3 cases reports of ITP following Pfizer and J&J:
3 cases: recurrent AvWD and acquired hemophilia A after Moderna, PNH flare following Moderna, and ITP flare following Moderna:
3 cases of ITP in elderly patients following vaccination:
36 Cases of ITP following Pfizer and Moderna:
PE, TIA, and thrombocytopenia after J&J:
DVT and PE and positive HIT panel following mRNA Vaccine:
3 patients with venous thromboembolism following mRNA vaccination:
Thrombosis with Thrombocytopenia following Moderna:
TTP Following Pfizer:
Acquired TTP following Pfizer:
TTP in an adolescent following Pfizer:
Thrombocytopenia in a teen with sickle cell disease following Pfizer:
Safety warning for AstraZeneca in patients with sickle cell disease:
5 cases of prothrombotic immune thrombocytopenia after AstraZeneca:
20 cases of Thrombocytopenia following Pfizer and Moderna:
Review of 50 cases of thrombocytopenia following Astrazeneca, Pfizer, Moderna:
68yoF with extensive thrombosis after AstraZeneca:
Thrombotic Thrombocytopenia after AstraZeneca: Autopsy findings:
Fatal ICH due to Thrombotic Thrombocytopenia following AstraZeneca:
Five cases with a combination of cerebral venous thrombosis, intracerebral hemorrhage and thrombocytopenia following AstraZeneca:
Confusion and abdominal pain due to VITT following vaccination:
Fatal thromboembolism in a patient with preexisting thrombocytopenia following AstraZeneca:
Malignant CVA due to VITT following AstraZeneca:
3 cases of immune thrombocytopenia following AstraZeneca in Thailand:
Treatment Guide to Thrombotic Thrombocytopenia Following Vaccination:
Successful venous thromboprophylaxis in a patient with AstraZeneca induced VITT:
Autoimmunity roots of the thrombotic events following COVID vaccination:

Thrombosis post COVID-19 Vaccinations

Potential link to ACE pathways:
Platelet activation and modulation in thrombosis with thrombocytopenia syndrome associated with AstraZeneca:
The known knowns and known unknowns of vaccine-induced thrombotic thrombocytopenia:
Skin, nose, and gingival bleeding episodes after AstraZeneca: a large population-based cohort study:
Haemophagocytosis and atypical lymphocytes on bone marrow biopsy following vaccination:
3 cases of HLH following AstraZeneca:
Coagulopathies after vaccination against SARS-COV-2 may be derived from a combo of spike protein and adenovirus vector-triggered signaling pathways:
The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia:

Excess VaXXine Injuries and Oncology

Axillary lymphadenopathy following mRNA vaccination:
Ipsilateral axillary adenopathy following mRNA vaccination:
4 cases of axillary adenopathy following mRNA vaccination:
Axillary adenopathy following AstraZeneca resulting in possible misinterpretation of PET scan in metastatic melanoma patient:
163 cases of axillary adenopathy following Pfizer:
Incidence of axillary adenopathy on Breast Imaging following Vaccination:
Supraclavicular lymphadenopathy following Pfizer:
Cervical lymphadenopathy following Pfizer:
13 cases of Cervical lymphadenopathy:
50yoM with adenopathy following Pfizer:
Review of 24 cases of lymphadenopathy and their ultrasound findings in the US:
Kikucki-Fujimoto disease following Pfizer:
Mammographic and sonographic findings in the breast and axillary tail following vaccination:
Vaccine related unilateral axillary lymphadenopathy:pattern on screening breast MRI:
Evolution of lymphadenopathy at PET/MRI after vaccination:
Axillary lymphadenopathy after COVID vaccination in patients with thoracic malignancy:
DOTATATE PET-avid axillary lymph node after injection of the Johnson & Johnson:
DOTATOC-avid lymphadenopathies induced by mRNA vaccination:
3 cases of supraclavicular and axillary lymphadenopathy induced by vaccination on 18F-Fluorthanatrace, 68Ga-DOTATATE, and 18F-Fluciclovine PET/CT: uptake in axillary lymph nodes after vaccination: a pitfall case of highly suspicious lymph nodes metastases of malignant melanoma: left axillary nodes and intense diffuse splenic uptake and moderate diffuse bone marrow uptake on PET 1 week after vaccination:
Vaccination effect on tracer uptake with FDG-PET/CT:
Abnormal PET following vaccination:
Positive PET following vaccination:
False Positive FDG PET CT after vaccination in a woman treated for metastatic breast cancer: day after mass COVID vaccination: higher hypermetabolic lymphadenopathy detection on PET/CT and impact on oncologic management:
Temporal metabolic response to mRNA vaccinations in oncology patients:
Thymic hyperplasia after mRNA vaccination:
Fatal systemic capillary leak syndrome after Johnson and Johnson vaccination in a multiple myeloma patient:
Moderna vaccination mimicking lymph-node progression in a patient with melanoma:
Post vaccination lymphadenopathy: report of cytological findings from fine needle aspiration biopsy:

Rituximab-induced acute lympholysis and pancytopenia after Moderna in a 71yoM with b-cell lymphoplasmacytic lymphoma:

Excess VaXXine Injuries in Dermatology/Plastic Surgery

60yo with Steven Johnson Syndrome:
Steven Johnson Syndrome following Pfizer:
Pemphigus Vulgaris:
Morbilliform Rash:
Pityriasis-rosea like eruption post-vaccination in a young male:
Pityriasis rosea following Pfizer:
66yoM with Pityriasis rosea after Pfizer:
1 case of Pityriasis rosea and 3 cases of urticaria following Pfizer:
A case series of Pityriasis rosea following vaccination:
Two cases of papulo-pustular rosacea-like eruptions following Pfizer and AstraZeneca:
Pityriasis rubra pilaris following Astra Zeneca:
Pityriasis rubra pilaris in 72yoM following Astra Zeneca:
Pityriasis Rubra Pilaris like eruption following Pfizer:
3 cases of new onset acral hand lesions following mRNA vaccine:
2 patients with eczematous cutaneous reactions following Pfizer:
New onset synovitis and palmoplantar psoriasis flare up after Pfizer:
Exacerbation of Hailey-Hailey Disease following mRNA vaccination:
New onset lichen planus following Pfizer:
Lichen striatus:
Purpura annularis telangiectodes following Pfizer:
Flagellate Purpura following AstraZeneca:
Symmetrical drug related intertriginous and flexural exanthema like eruption following AztraZeneca:
Vitiligo following Pfizer:
Vitiligo in a Ulcerative Colitis Patient following mRNA vaccination:
Bacillus Calmette-Guerin scar flare after mRNA vaccination:
Palms and Soles Itchiness following Pfizer:
Resistant pruritis skin rash following Pfizer:
Necrotic eschars at injection sites one week after 2nd dose of Pfizer:
Facial Pustular Neutrophilic Eruption following mRNA vaccine:
Acute generalized exanthematous pustulosis induced by Moderna:
AstraZeneca induced acute localized exanthematous pustulosis:
Delayed local skin reactions:
Delayed skin reactions following mRNA vaccine:
11 patients with delayed skin reaction after mRNA vaccination:
12 Patients with Delayed Local Reactions:
16 patients delayed hypersensitivity reactions after Moderna:
138 Delayed Hypersensitivity Reactions following vaccination:
Delayed local Hypersensitivity reactions: a 6 month retrospective study:
Delayed cutaneous hypersensitivity reaction following AstraZeneca:
Cutaneous skin manifestation following Moderna with Hypersensitivity reaction Histopathology:
2 cases of delayed local reactions following Moderna:
4 cases of cutaneous hypersensitivity reactions following Moderna:
5 Japanese cases of delayed large local reactions to Pfizer vaccination:
13 cases delayed local reactions following mRNA vaccine:
COVID Vaccine arm:
COVID arm following Moderna: histologic features:
Covid vaccine arm may present after both mRNA vaccines vaccination:
405 cases of dermatologic reactions following Pfizer, Moderna, and Astra Zeneca:
Erythema Migrans like rash after Moderna:
Bullous Drug Eruption Rash following Moderna:
Bullous eruption following Pfizer:
Bullous Fixed Drug Eruption following AstraZeneca:
Atypical erythema multiforme related to Pfizer vaccine:
Soft Tissue Filler Inflammatory Reaction after vaccination:
Immune Response to fillers and breast implants after vaccination:
Breast Implant seroma after mRNA vaccine:
L Breast Implant Capsular Contracture following Moderna vaccination:
COVID-toes after mRNA vaccination:
Leukoclastic vasculitis:
Urticarial Vasculitis following vaccination:
Urticarial Vasculitis:
Small vessel vasculitis after Astra Zeneca:
Cutaneous small vessel vasculitis following J&J:
Cutaneous lymphocytic vasculitis following mRNA vaccine:
Pfizer induced reactivation of varicella and resulting small vessel vasculitis:
2 cases of skin color discoloration following mRNA vaccination:
A case series of rare cutaneous adverse events following vaccination: Vaccine Induced Skin Rash:
A Case series of Cutaneous vaccine reactions at Loma Linda University:
Clinicopathological features of cutaneous reactions after mRNA vaccines, 11 cases:
3 cases of vesiculobullous non-IgE-mediated cutaneous reactions to Pfizer:
A narrative review of cutaneous and hypersensitivity reactions:
SARS-CoV-2 Vaccines and the Skin:
Excess VaXXine Injuries and Ophthalmology:
Acute Macular Neuroretinopathy after AstraZeneca:
Acute macular neuroretinopathy following Pfizer:
Acute Central Serous Retinopathy after Pfizer:
Reduction of Visual Acuity following Pfizer:
Corneal graft rejection after Pfizer vaccination:
Bilateral Retinal Detachments 10 days after mRNA vaccination 22yoF:
Central Retinal Vein Occlusion occuring immediately after 2nd dose of mRNA vaccine:
Transient Oculomotor palsy following mRNA. Vaccine:
Anterior Uveitis following Pfizer:
21 cases of Uveitis following mRNA vaccination:
A case of bilateral arteritic anterior ischemic optic neuropathy and a case of bilateral acute zonal occult outer retinopathy after mRNA vaccination:
Vaccination and Bilateral Multifocal Choroiditis:
34yoM with bilateral multifocal choroiditis following 2nd dose vaccination:
Acute painless bilateral blurring of vision following Pfizer due to Vogt-Koyanagi-Hara disease:
Eyelid erythema after Pfizer vaccination:
Reactivation of herpes simplex keratitis following AstraZeneca vaccination:
2 cases of Ipsilateral zoster opthalmicus after Moderna and Johnson and Johnson: immune mediated keratolysis following AstraZeneca:
COVID-19, COVID-19 vaccinations, and subsequent abnormalities in the retina: causation or coincidence?
3 cases of Tinnitus following mRNA vaccination:
18 cases of idiopathic sensorineural hearing loss, tinnitus, and/or vertigo following Moderna/Pfizer:
Tinnitus/cochleopathy following AstraZeneca:
Lipschutz ulcers after AstraZeneca:
Herpes Zoster following Moderna:
Herpes Zoster reactivation following Moderna:
Ramsy Hunt syndrome following mRNA vaccination:
A case series of Herpes Zoster following AstraZeneca:
2 cases of herpes zoster following Pfizer:
2 cases of herpes zoster in healthy young adults following vaccination:
3 cases of Herpes Zoster following Vaccination (Moderna and AstraZeneca):
3 cases of Herpes Zoster after covid vaccination in patients with chronic urticaria being treated with cyclosporine: cases of Herpes Zoster (2 pfizer, 2 astrazeneca):
6 cases of Herpes Zoster following Pfizer:
A case of varicella-zoster virus after Pfizer:
Varicella zoster reactivation and mRNA vaccines as a trigger: cases of HSV and VZV reactivation following mRNA vaccination:
Multisystem inflammatory syndrome in an adult following Pfizer (MIS-V): cases of Multisystem Inflammatory Syndrome after Pfizer:
Hypertension following mRNA vaccination:
POTS following Pfizer:
Vaccine induced interstitial lung disease in 86yoM after mRNA vaccine:
Vaccine induced interstitial lung disease: Embolus following Moderna:
Concerns for Pfizer vaccine failure to wildtype variants after Delta and vaccine induced enhanced illness, as demonstrated in a mice model:
International call for vaccine adverse reaction investigation:
Concerns about the lipid nanoparticle in the mRNA contributing to adverse reactions:
Medscape Health Care Professional Adverse Reactions:
Facebook link to reactions:
Need More Scientific Evidence to Convince YOU That the Corona VaXXine is NOT Safe or Effective?
The following link below will take you to over 1250 Peer-reviewed publications that provide the scientific proof that the Corona VaXXine is NOT safe or NOT effective and is causing injury and death -